Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients (pts) with advanced renal cell cancer (RCC)

被引：13
|
作者：
Wolter, P.
Stefan, C.
Decallonne, B.
Dumez, H.
Fieuws, S.
Wildiers, H.
Clement, P.
Debaere, D.
Van Oosterom, A.
Schoffski, P.
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] Catholic Univ Louvain, B-3000 Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5126
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Thyroid dysfunction in patients (pts) with metastatic renal cell cancer (RCC) treated with sorafenib
    Clement, P.
    Wolter, P.
    Stefan, C.
    Decallonne, B.
    Dumez, H.
    Wildiers, H.
    Schoffski, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Sunitinib in patients (pts) with unresectable primary renal cell carcinoma (RCC)
    Wood, L.
    Garcia, J. A.
    Elson, P.
    Salas, R. N.
    Lane, B. R.
    Klein, E.
    Stephenson, A.
    Dreicer, R.
    Campbell, S. C.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Sunitinib-related macrocytosis in patients with advanced renal cell cancer (RCC)
    Price, J. A.
    Shaarbaf, R.
    Wood, L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Treatment sequencing following first-line sunitinib in patients (pts) with advanced renal cell carcinoma (RCC)
    Gore, M. E.
    Hutson, T. E.
    Lin, X.
    Korytowsky, B.
    Lechuga, M. J.
    Matczak, E.
    Figlin, R. A.
    Bukowski, R.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
  • [5] A pilot study of the safety, efficacy, and effects on functional imaging of the combination of cG250 and sunitinib in patients (pts) with advanced renal cell carcinoma (RCC).
    Ciprotti, M.
    Davis, I. D.
    Pook, D. W.
    Lee, F. T.
    Cavicchiolo, T.
    Lee, S. T.
    Chappell, B.
    O'Keefe, G. J.
    Tochon-Danguy, H.
    Smyth, F. E.
    Hopkins, W.
    Scott, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] A Pilot Study of the Safety, Efficacy and Effects On Functional Imaging of the Combination of CG250 and Sunitinib in Patients (pts) with Advanced Renal Cell Carcinoma (RCC)
    Ciprotti, M.
    Davis, I. D.
    Pook, D. W.
    Lee, F. T.
    Lee, S. T.
    O'Keefe, G. J.
    Tochon-Danguy, H.
    Smyth, F. E.
    Hopkins, W.
    Scott, A. M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 99 - 99
  • [7] Acid suppression therapy impairs sunitinib efficacy in renal cell cancer (RCC)
    Chu, Michael P.
    Ha, Vincent
    Ngo, Margaret
    Ghosh, Sunita
    Chambers, Carole R.
    Sawyer, Michael B.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Evaluation of soluble KIT (sKIT) as a potential surrogate marker for TTP in sunitinib malate (SU)-treated patients (pts) with advanced GIST
    Blackstein, M.
    Huang, X.
    Demetri, G. D.
    Casali, P. G.
    Garrett, C. R.
    Schoffski, P.
    Shah, M. H.
    Verweij, J.
    Baum, C. M.
    DePrimo, S. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Phase II trial of linifanib in patients with advanced renal cell cancer (RCC) after sunitinib failure
    Tannir, N. M.
    Wong, Y.
    Kollmannsberger, C. K.
    Ernstoff, M. S.
    Perry, D. J.
    Appleman, L. J.
    Posadas, E. M.
    Qian, J.
    Ricker, J. L.
    Michaelson, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Sunitinib (SU) Treatment (Trx) Patterns and Toxicity in Patients (Pts) with Advanced Renal Cell Carcinoma (RCC) in United Kingdom (UK)
    Hawkins, Robert
    Wagstaff, John
    Nathan, Paul
    Sarda, Sujata P.
    Vekeman, Francis
    Korves, Caroline
    Dasgupta, Sonali
    O'Mara, Sylwia
    Fitton, Simon
    Hayers, Jayne
    Tham, Christopher
    Luka, Andi
    Wei, Robert
    Mykletun, Andrew
    Neary, Maureen P.
    Duh, Mei Sheng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S70 - S70
12345